• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC PUERTO RICO OPERATIONS CO. SYNCHROMED II; PUMP, INFUSION, IMPLANTED, PROGRAMMABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC PUERTO RICO OPERATIONS CO. SYNCHROMED II; PUMP, INFUSION, IMPLANTED, PROGRAMMABLE Back to Search Results
Model Number 8637-40
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Muscle Weakness (1967); Sedation (2368); Loss of consciousness (2418); Lethargy (2560)
Event Date 10/19/2018
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
Information was received from a healthcare provider via a company representative regarding a patient receiving gablofen 2000mcg/ml at 150mcg/day via an implantable pump.The indication for use was intractable spasticity.On (b)(6) 2019 it was reported that since the patient¿s first refill, the patient has been having episodes.The reporter stated that one refill they increased the medication from 130mcg/day to 150mcg/day and the same lot of medication had been in there since.Per the reporter, the patient¿s mother reported the patient has been having episode about every 10 days where she is sedated and unresponsive.The mom says these episodes last between a couple of hours to a couple of days and nothing seems to make it better, the patient eventually just comes out of it.They performed a dye study today and everything was normal, they looked at the rollers during the dye study and saw the rollers move 90 degrees.No further complications were reported or anticipated.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
On 2019-mar-22, additional information was received from the healthcare professional (hcp).The hcp reported the cause of the symptoms has not been determined.The dose has been decreased from 150 mcg/day to 120 mcg/day.The pump was refilled early to asses actual volume compared to estimated volume.The pump was filled with 20 ml given the low daily dose.The next refill was scheduled for (b)(6) 2019.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
On 2019-may-28, additional information was received from the healthcare professional (hcp).The hcp reported the cause of the patient's symptoms has not been determined.The hcp reported further actions taken; management coordinated with neurology: monitor for resolution of symptoms of hypotonia with itb pump at minimal rate and oral baclofen.Differential diagnosis includes autonomic failure per neurology.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
On 2019-may-03, additional information was received from the healthcare professional (hcp).Additional information reported the refill was moved up to (b)(6) 2019 because the patient had a very long episode of lethargy and loss of tone following the dye and roller study on (b)(6) 2019.Upon interrogation of the patient's pump, estimated residual volume was 28.8 ml and logs showed no alarms or motor stalls.During the refill, approximately 29 ml of baclofen was aspirated.Patient's dose was decreased from 150 mcg/day to 120 mcg/day and she was refilled with 20 ml (not 40 ml).Of note, patient was monitored in the hospital with continuous eeg and an episode of lethargy/hypotonia was captured.Subsequently, pump rate was turned down to minimum rate; she has supplemental enteral baclofen.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNCHROMED II
Type of Device
PUMP, INFUSION, IMPLANTED, PROGRAMMABLE
Manufacturer (Section D)
MEDTRONIC PUERTO RICO OPERATIONS CO.
road 31, km. 24, hm 4
ceiba norte industrial park
juncos PR 00777
Manufacturer (Section G)
MEDTRONIC PUERTO RICO OPERATIONS CO.
road 31, km. 24, hm 4
ceiba norte industrial park
juncos PR 00777
Manufacturer Contact
lisa woodward clark
7000 central avenue ne rcw215
minneapolis, MN 55432
7635263920
MDR Report Key8377377
MDR Text Key137366918
Report Number3004209178-2019-04195
Device Sequence Number1
Product Code LKK
UDI-Device Identifier00643169530126
UDI-Public00643169530126
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P860004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup
Report Date 06/03/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/28/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/14/2019
Device Model Number8637-40
Device Catalogue Number8637-40
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/30/2019
Date Device Manufactured02/15/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age12 YR
Patient Weight34
-
-